Targanta Therapeutics
Innovative blockchain solutions for secure patient data storage and advanced crypto trading tools
About Targanta Therapeutics
Targanta operates at the intersection of healthcare and blockchain technology, providing innovative solutions for the secure storage of patient data. By leveraging blockchain, Targanta ensures data integrity, security, and accessibility, addressing critical needs in the healthcare sector. The company also offers advanced tools for crypto trading, including crypto robots that enhance trading efficiency. Targanta serves healthcare providers, researchers, and traders, operating in the healthcare technology and financial technology markets. The business model revolves around subscription-based services and transaction fees, generating revenue through continuous service provision and trading activities.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jan 2009 | $42M | $42M | The Medicines Company | — |
| IPOOther financing | Oct 2007 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Targanta Therapeutics is 1.3K monthly website visits, up 97% over the last three months. Targanta Therapeutics's team declined 4.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Targanta Therapeutics in the Cambridge ecosystem
The Targanta Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Bain Capital
Radius Ventures
OrbiMed
Skyline Ventures
Other known investors1 additional known investor
The Medicines Company
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Targanta Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Targanta Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










